Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | GRDN | FMS |
|---|---|---|
| Price | $42.10 | $22.65 |
| Change today | ▼ 0.66% | ▲ 1.80% |
| Market cap | $2.67B | $12.05B |
| Return, 3 months | +5.3% | -6.4% |
| Return, year to date | +39.9% | -1.1% |
| Return, 1 year | +77.3% | -11.9% |
| P/E (TTM) | 40.5 | 12.2 |
| P/B | 10.9 | 0.9 |
| P/E percentile vs own 5y | 55th | 15th |
| Dividend yield | – | 3.77% |
| Revenue growth (YoY, latest qtr) | – | +1.4% |
| Net profit growth (YoY) | – | +7.7% |
| Gross margin | – | 26.4% |
| Operating margin | – | 10.2% |
| Net margin | – | 4.8% |
| Return on equity | – | 7.3% |
| Analyst target vs. price | +18.2% | +4.1% |
| Analyst buy share | 100% | 0% |
| RSI (14) | 51 | 50 |
| 30-day volatility | 38.2% | 20.0% |
| Max drawdown, 1 year | -15.4% | -26.3% |
| Trend read | Leaning bullish | Leaning bullish |
| Analyst consensus | Buy | Sell |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
